2020 Virtual ESMO Review
2020 ESMO Update on Non-Hodgkin Lymphomas: Does BETi CC-90010 Lead to Clinical Responses in R/R DLBCL? How Effective Is LSD1 Inhibitor CC-90011 MZL?
By
2020 Virtual ESMO Review
FEATURING
Jennifer Amengual
By
2020 Virtual ESMO Review
FEATURING
Jennifer Amengual
Comments 0
Login to view comments.
Click here to Login
